MetLife, Inc. (NYSE:MET) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. reduced its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 5.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 133,677 shares of the financial services provider's stock after selling 8,005 shares during the period. Corebridge Financial Inc.'s holdings in MetLife were worth $10,945,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in MET. CX Institutional raised its stake in shares of MetLife by 15.9% in the fourth quarter. CX Institutional now owns 68,005 shares of the financial services provider's stock valued at $5,568,000 after acquiring an additional 9,337 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of MetLife by 109.2% during the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock worth $722,727,000 after purchasing an additional 4,606,748 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in MetLife by 27.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider's stock valued at $1,116,000 after buying an additional 2,940 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in MetLife by 1.7% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider's stock valued at $63,559,000 after buying an additional 12,723 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC purchased a new stake in MetLife during the 4th quarter worth about $259,000. 94.99% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

MetLife Stock Performance

NYSE:MET traded up $1.09 during mid-day trading on Monday, reaching $80.32. The stock had a trading volume of 5,392,281 shares, compared to its average volume of 3,277,523. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The business has a 50 day simple moving average of $83.16 and a 200 day simple moving average of $82.98. MetLife, Inc. has a twelve month low of $67.30 and a twelve month high of $89.05. The firm has a market capitalization of $54.72 billion, a price-to-earnings ratio of 13.45, a PEG ratio of 0.65 and a beta of 1.04.

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were paid a dividend of $0.545 per share. The ex-dividend date of this dividend was Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.71%. MetLife's dividend payout ratio (DPR) is presently 36.52%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Barclays cut their target price on MetLife from $96.00 to $95.00 and set an "overweight" rating on the stock in a research report on Friday, February 7th. BMO Capital Markets initiated coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 target price on the stock. JPMorgan Chase & Co. upped their price target on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research report on Tuesday, January 7th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $100.00 to $98.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 12th. Finally, Cowen reiterated a "buy" rating on shares of MetLife in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $94.58.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.